United States: Four Additional IPRs Filed By Merck Challenging The Johns Hopkins University Pembrolizumab Patents - Venable LLP

On March 13, 2024, Merck Sharp & Dohme, LLC ("Merck") filed four additional IPRs challenging The Johns Hopkins University ("JHU") patents covering methods of treatment using pembrolizumab...